Safety Alerts & Recalls

Search all Safety Alerts & Recalls

Latest Alerts

New black box warning
The FDA recently announced an additional boxed warning to the label of Regranex Gel 0.01% (becaplermin), a topical cream used for the treatment of leg and foot ulcers that are not healing in diabetic patients. The boxed warning advises doctors and patients about the increased risk of death from cancer that was seen in patients treated with three or more tubes of Regranex compared with those patients who did not use Regranex. This is a follow-up communication to a Regranex safety alert posted by the FDA in March 2008. For more information, please visit: http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm094968.htm
Learn More

Selected recall of morphine sulfate 60 mg extended release tablets
ETHEX Corporation has initiated a voluntary recall of a single lot of morphine sulfate 60 mg extended release tablets (Lot No. 91762) which is used to treat pain. These tablets may contain more drug than appropriate. The lot was distributed by ETHEX Corporation under an "ETHEX" label between April 16th and April 27th of 2008. For more information, please visit: http://www.fda.gov/Safety/Recalls/ArchiveRecalls/2008/ucm112456.htm
Learn More